Socio-economic burden of atrial fibrillation in the Russian Federation: dynamics over 12 years

Relevance. Diseases of the cardiovascular system remain one of the main causes of death worldwide. The incidence of cardiovascular and circulatory diseases increased by one third between 1990 and 2010. The prevalence of atrial ﬁbrillation (AF) ranges from 2.5–3.5% in the general population of patien...

书目详细资料
发表在:	Качественная клиническая практика
Main Authors:	A. P. Kasimova, O. S. Tufanova, A. S. Kolbin
格式:	文件
语言:	俄语
出版:	Izdatelstvo OKI 2023-07-01
主题:	мерцательная аритмия бремя заболевания прямые затраты антикоагулянты тромбопрофилактика
在线阅读:	https://www.clinvest.ru/jour/article/view/664

相似书籍

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
由: L. N. Chikhireva, et al.
出版: (2015-12-01)

ESTIMATING ATRIUM CONDITION BY MEANS OF HIGH RESOLUTION ECG AND ECHOCARDIOGRAPHY IN PATIENTS WITH PAROXYSMAL ATRIAL FLUTTER
由: G. I. Storozhakov, et al.
出版: (2001-06-01)

СЛУЧАЙ ГИГАНТСКОЙ АНЕВРИЗМЫ ПРАВОГО ПРЕДСЕРДИЯ У ПАЦИЕНТА СЕМИДЕСЯТИ ВОСЬМИ ЛЕТ
由: И. А. Шелестова, et al.
出版: (2015-10-01)

Socio-economic burden of COVID-19 in the Russian Federation
由: A. S. Kolbin, et al.
出版: (2020-05-01)

Social-economic burden of severe atopic dermatitis in the Russian Federation
由: I. S. Krysanov, et al.
出版: (2020-04-01)

CОВРЕМЕННЫЕ СТРАТЕГИИ ПРОФИЛАКТИКИ ТРОМБОЭМБОЛИЧЕСКИХ ОСЛОЖНЕНИЙ У ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ
出版: (2016-12-01)

COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION
由: A. V. Rudakova, et al.
出版: (2015-09-01)

Analysis of drug prevention of venous thromboembolic complications in hip arthroplasty (review)
由: E. N. Bochanova, et al.
出版: (2016-09-01)

Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19
由: V. A. Otdelenov, et al.
出版: (2020-10-01)

ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL)
由: M. A. Demidova, et al.
出版: (2015-12-01)

Influence of dupilumab on the economic burden of severe asthma and atopic dermatitis
由: I. S. Krysanov, et al.
出版: (2020-09-01)

Analysis the cost of chronic obstructive pulmonary disease in Russian Federation
由: I. S. Krysanov
出版: (2018-06-01)

АДЕКВАТНОСТЬ АНТИТРОМБОТИЧЕСКОЙ ТЕРАПИИ ПРИ НЕКЛАПАННОЙ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ В РЕАЛЬНОЙ КЛИНИЧЕСКОЙ ПРАКТИКЕ
由: Е. И. Баранова, et al.
出版: (2015-07-01)

Pharmacoeconomic evaluation of apixaban use for the treatment and prevention of venous thromboembolism in the general population and patients with oncological diseases
由: A. S. Kolbin, et al.
出版: (2023-03-01)

Social-economic burden of Pompe disease with late onset in the Russian Federation
由: A. S. Kolbin, et al.
出版: (2019-04-01)

Modeling of the impact of biological drugs in the economic burden of severe asthma
由: S. K. Zyryanov, et al.
出版: (2020-01-01)

Фармакоэкономическая экспертиза дронедарона при мерцательной аритмии у больных старших возрастных групп
出版: (2018-06-01)

PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
由: A. V. Rudakova
出版: (2015-09-01)

Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases
由: A. S. Kolbin, et al.
出版: (2018-05-01)

Исследование медико-социальных проблем эпилепсии в России
出版: (2018-06-01)

Changes in the oral mucosa and general indicators with COVID 19 (SARS-CoV-2): a single-center descriptive study
由: Z. S. Khabadze, et al.
出版: (2020-08-01)

Cystic fibrosis as a social-economic burden
由: A. S. Kolbin, et al.
出版: (2021-02-01)

ALGORITHM FOR MANAGEMENT OF HYPERTENSIVE PATIENTS UNDERWENT UROLOGY INTERVENTIONS
由: S. S. Davydova
出版: (2015-09-01)

Пальпация при сердечно-сосудистых заболеваниях
由: Юрий Иванович Строев, et al.
出版: (2019-03-01)

Клинико-экономический анализ профилактики послеоперационных венозных тромбоэмболических осложнений
出版: (2018-06-01)

Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome
由: O. I. Ivakhnenko, et al.
出版: (2022-05-01)

Интеграция бюджетного и управленческого учета в учреждениях высшего профессионального образования. Жоғары кәсіптік білім беру мекемелеріндегі бюджеттік және басқарушылық есепке алу интеграциясы.
由: G Sabyrova
出版: (2016-04-01)

АЛТАЙСКИЙ КРАЙ: ПОСЛЕДСТВИЯ ПАНДЕМИИ COVID-19 И НАПРАВЛЕНИЯ ИХ НИВЕЛИРОВАНИЯ
由: Александр Яковлевич Троцковский, et al.
出版: (2021-06-01)

CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION
由: V. N. Shishkova
出版: (2015-09-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
由: E. A. Belikov, et al.
出版: (2015-09-01)

CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY
由: Yu. A. Bunin
出版: (2016-01-01)

SOCIO-ECONOMIC DAMAGE BY ACUTE CORONARY SYNDROME IN RUSSIAN FEDERATION
由: A. V. Kontsevaya, et al.
出版: (2016-01-01)

INCIDENCE, MORTALITY AND PREVALENCE AS INDICATORS OF TUBERCULOSIS BURDEN IN WHO REGIONS, COUNTRIES OF THE WORLD AND THE RUSSIAN FEDERATION. PART 1. TUBERCULOSIS INCIDENCE AND PREVALENCE
由: I. A. Vаsilyevа, et al.
出版: (2017-06-01)

Затраты вспомогательного производства как объект управленческого учета. Басқарушылық есептің нысаны ретінде көмекші өндірістің шығындары
由: G. N. Appakova, et al.
出版: (2016-04-01)

Мультифакторный клиникоэкономический анализ эффективности применения современных атипичных антипсихотиков у больных с шизофренией
出版: (2018-06-01)

Socioeconomic and global burden of COVID-19
由: A. S. Kolbin, et al.
出版: (2021-04-01)

ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS AFTER CARDIOEMBOLIC STROKE: EVALUATION OF TREATMENT ADHERENCE IN REAL PRACTICE (Cohort study “APOLLON”)
由: I. A. Zolotovskaya, et al.
出版: (2017-08-01)

PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
由: E. D. Kosmacheva, et al.
出版: (2015-09-01)

Высокоэффективные оральные антикоагулянты
由: Editorial Article
出版: (2014-12-01)

ВЫЯВЛЕНИЕ ФАКТОРОВ РИСКА И ПРЕДИКТОРОВ ВЕНОЗНЫХ ТРОМБОЭМБОЛИЧЕСКИХ ОСЛОЖНЕНИЙ
由: Андрей Сергеевич Галенко, et al.
出版: (2025-08-01)